Veterinary Infectious Disease Diagnostics Market Size, Share and Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2024 – 2032

Veterinary Infectious Disease Diagnostics Market Size

The global veterinary infectious disease diagnostics market experienced robust growth in 2024 and is expected to grow at a decent CAGR during 2025-2034, driven by several key factors, including the increasing incidence of zoonotic diseases, rising pet ownership, and the growing demand for rapid and accurate diagnostic tools in both companion animals and livestock. The 2024 Global Pet Parent Study estimated the global pet population was 1 billion. Cats were found more popular among the male population than in women, with 52% of men owning cats compared to 48% of women. Out of 56% of individuals who owned a pet, 47% were first-time pet owners. The demand for timely, accurate, and effective diagnostic tools is rising, driven by growing awareness of the role of early diagnosis in preventing the spread of disease and improving animal health outcomes. The demand for diagnostic solutions in the veterinary sector is fueled by the rising prevalence of zoonotic diseases (diseases transmitted from animals to humans), advances in diagnostic technologies, and an increased focus on improving food safety standards and animal welfare.
 

The awareness surrounding the importance of early diagnosis to prevent outbreaks, coupled with advancements in diagnostic technologies such as point-of-care devices and multiplex assays, is also fueling market growth. Additionally, the rising focus on animal welfare and food safety is driving the adoption of advanced diagnostic solutions. However, the high cost of diagnostic tests, limited access to advanced diagnostic technologies in rural or underserved areas, and regulatory hurdles that can delay the approval and widespread adoption of new diagnostic tools may hinder the market growth.
 

Veterinary Infectious Disease Diagnostics Market Trends

The veterinary infectious disease diagnostics industry is witnessing several emerging trends, primarily driven by technological advancements and the increasing need for faster, more accurate diagnostic solutions. One notable trend is the rise of point-of-care (POC) diagnostic tools, which allow for rapid, on-site testing with results available in a short time frame. These devices are particularly beneficial in emergency veterinary care and rural settings where access to laboratory facilities may be limited. Additionally, the adoption of molecular diagnostic techniques, such as PCR (Polymerase Chain Reaction) and next-generation sequencing (NGS), is gaining momentum due to their ability to detect pathogens with high sensitivity and specificity. These methods enable veterinarians to diagnose diseases at the genetic level, providing a more precise understanding of infections. Another trend is the development of multiplex assays that can simultaneously test for multiple pathogens, reducing the time and cost of testing.
 

Veterinary Infectious Disease Diagnostics Market Analysis

The viral infections segment in the veterinary infectious disease diagnostics market is projected to exhibit significant growth through 2034 driven by the rising incidence of viral outbreaks in both companion animals and livestock. The prevalence of viral diseases, including canine parvovirus, feline leukemia virus, avian influenza, and foot-and-mouth disease, has become a major concern for veterinarians globally. These viral infections are challenging to control and can have severe consequences, including high mortality rates and reduced productivity, particularly in agricultural settings. As a result, the demand for reliable and rapid diagnostic solutions has intensified. The diagnostic techniques for viral infections typically involve polymerase chain reaction (PCR) tests, enzyme-linked immunosorbent assays (ELISA), and rapid antigen tests.
 

PCR tests are highly effective in detecting viral DNA or RNA, enabling veterinarians to diagnose infections quickly and accurately. The rapid identification of viral pathogens is crucial for controlling outbreaks and preventing the spread of diseases in animal populations, especially in high-density farming environments. PCR-based diagnostics are particularly valued for their accuracy and sensitivity, making them indispensable in diagnosing viral infections. The increasing awareness of zoonotic diseases is also fueling demand for viral diagnostics in veterinary care. For example, diseases such as avian influenza and foot-and-mouth disease not only threaten animal health but can also have significant public health implications. The need for effective diagnostics to monitor and control these diseases has made the viral infections segment an essential driver of the market. With advancements in diagnostic technology and the increasing prevalence of viral outbreaks, this segment is expected to continue growing throughout the forecast period.
 

The immunodiagnostics segment in the veterinary infectious disease diagnostics market held a significant share in 2024, helping in diagnosing a wide range of infections in animals. Immunodiagnostic tests are based on detecting specific antibodies or antigens in animal samples such as blood, urine, or saliva. These tests provide rapid and reliable results, making them indispensable for veterinary professionals who need to diagnose infections in real time and implement appropriate treatments. Immunodiagnostic tests are used to detect bacterial, viral, and parasitic infections, including Lyme disease, toxoplasmosis, brucellosis, and ehrlichiosis. Point-of-care (POC) diagnostic devices, which allow for real-time testing at the point of care, are an emerging trend in the immunodiagnostics segment. These devices are particularly beneficial for veterinarians in rural or underserved areas where access to advanced laboratory facilities may be limited. They enable veterinarians to perform tests during routine clinical visits, improving diagnostic efficiency and facilitating prompt treatment decisions. The development of multiplex assays, which can detect multiple pathogens simultaneously, is another key advancement in the immunodiagnostics space.
 

North America veterinary infectious disease diagnostics market held the largest share in 2024. The region is expected to continue its dominance during 2025-2034, driven by high healthcare spending, technological advancements in diagnostic tools, and the rising prevalence of infectious diseases in both companion animals and livestock. The United States and Canada are key contributors to the market in North America, with a well-established veterinary healthcare system and regulatory environment that supports the use of advanced diagnostic tools. One of the key drivers for the veterinary infectious disease diagnostics market in North America is the growing awareness of zoonotic diseases. With the increasing recognition of the potential for diseases to transfer from animals to humans, both veterinary professionals and the public are becoming more focused on preventing the spread of these diseases. The region is also home to several leading manufacturers and research institutions that are developing new and innovative diagnostic solutions. This includes the development of multiplex assays, point-of-care testing devices, and other technologies designed to improve diagnostic speed and accuracy.
 

Veterinary Infectious Disease Diagnostics Industry Share

Key players involved in the veterinary infectious disease diagnostics industry are

• DRG Instruments GmbH
• Eurofins Technologies
• Zoetis
• Neogen Corporation
• Virbac
• Randox Laboratories, Ltd.
• Idexx Laboratories, Inc.
• Thermo Fisher Scientific
• NTBIO Diagnostics Inc.
• Chembio Diagnostic Systems, Inc.
   

Companies in the veterinary infectious disease diagnostics market are focusing on key strategies such as mergers and acquisitions, product innovations, partnerships, and regional expansions to strengthen their market presence. Major players are investing heavily in research and development to introduce advanced diagnostic tools, including rapid, accurate, and cost-effective solutions for veterinarians. Collaborations with research institutions and veterinary organizations are also common to improve diagnostic capabilities and expand their product portfolio. Additionally, companies are enhancing their distribution networks and improving customer support to increase market penetration, especially in emerging regions.
 

Veterinary Infectious Disease Diagnostics Industry News

• In October 2024, World Organization for Animal Health introduced ZOOSURSY, a new disease surveillance initiative funded by the European Union. The organization aimed to enhance sustainable health security in Africa through the implementation of a One Health approach.
   
• In February 2025, IDEXX Laboratories, Inc. announced the launch of a groundbreaking diagnostic tool aimed at improving the detection of infectious diseases in livestock. The new platform leverages advanced molecular diagnostics to provide rapid, accurate results for diseases such as avian influenza, foot-and-mouth disease, and African swine fever.